花园生物(300401) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥317,120,309.15, a decrease of 17.97% compared to ¥386,592,882.41 in the same period last year[6] - Net profit attributable to shareholders was ¥51,859,513.29, down 65.69% from ¥151,152,689.96 year-on-year[6] - Operating profit decreased to CNY 55,583,823.97, a decline of 68.7% from CNY 177,090,497.45 in Q1 2022[22] - Basic and diluted earnings per share for Q1 2023 were CNY 0.09, compared to CNY 0.28 in Q1 2022[24] - Total operating revenue for Q1 2023 was CNY 317,120,309.15, a decrease of 17.9% compared to CNY 386,592,882.41 in Q1 2022[22] - Total operating cost for Q1 2023 was CNY 269,882,876.30, up from CNY 234,074,731.77 in the same period last year[22] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 43.11% to ¥139,756,862.80 from ¥245,658,562.83 in the previous year[6] - Cash inflow from operating activities was CNY 488,520,775.06, an increase from CNY 465,917,742.62 in Q1 2022[26] - Total cash outflow from operating activities amounted to CNY 348,763,912.26, up 58.2% from CNY 220,259,179.79 year-on-year[27] - Cash inflow from financing activities reached CNY 1,414,803,000.00, significantly higher than CNY 255,880,000.00 in the previous year, marking a growth of 451.5%[27] - Net cash flow from financing activities was CNY 1,276,076,114.69, an increase of 533.5% compared to CNY 201,208,438.42 in the prior year[27] - The ending balance of cash and cash equivalents was CNY 1,852,183,602.49, up from CNY 731,816,265.22 year-on-year, representing an increase of 153.5%[27] Assets and Liabilities - Total assets increased by 31.55% to ¥5,435,505,587.57 from ¥4,131,859,509.89 at the end of the previous year[6] - Total liabilities rose to CNY 2,491,668,937.63, compared to CNY 1,559,684,578.10 in the previous year[21] - As of March 31, 2023, total current assets reached 2,693,749,556.25 RMB, up from 1,387,028,622.29 RMB at the beginning of the year[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 27,685[13] - Zhejiang Xiangyun Technology Co., Ltd. holds 26.20% of shares, amounting to 144,376,377 shares, with 74,600,000 shares pledged[13] - The top ten shareholders hold a combined total of 207,000,000 shares, representing a significant portion of the company's equity[13] Expenses and Costs - The company reported a 74.35% increase in management expenses to ¥36,885,830.24, primarily due to higher equity incentive costs and depreciation[9] - Interest expenses surged by 82.24% to ¥9,315,186.44, attributed to increased costs from convertible bonds[9] - Cash paid for various operating activities rose by 306.72% to ¥99,617,099.13, mainly due to increased marketing expenses[10] - The company paid CNY 59,317,697.09 in taxes, which is an increase of 72.9% compared to CNY 34,329,539.86 last year[27] - Cash paid to employees was CNY 47,089,422.12, an increase of 18.5% from CNY 39,855,621.37 in the previous year[27] Investment and Development - The company has ongoing research and development efforts, as indicated by the increase in development expenditures to 30,209,385.93 RMB from 25,455,115.40 RMB[19] - The company plans to continue expanding its market presence and investing in new product development to drive future growth[12] - The company plans to expand its market presence through the issuance of convertible bonds and potential new product developments[18] - The company issued 12 million convertible bonds at a face value of 100 RMB each, raising a total of 1.2 billion RMB, with a net amount of 1.186 billion RMB after expenses[18] Inventory and Cash Management - Inventory as of March 31, 2023, was 584,765,776.51 RMB, compared to 545,874,555.66 RMB at the beginning of the year[19] - The cash balance increased to 1,889,045,651.71 RMB from 554,909,447.09 RMB at the beginning of the year[19] Audit Status - The report for the first quarter was not audited[28]